Chimeric Therapeutics Limited

Chimeric Therapeutics Limited financial statements

Chimeric Therapeutics Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueAUD 3.97MEODHD
Net income−AUD 10.43MEODHD
Cash and equivalentsAUD 5.76MEODHD

Chimeric Therapeutics Limited financials on 6ix · Chimeric Therapeutics Limited on 6ix